03 Jun 2021 --- ADM Ventures, the corporate venture capital arm of ADM, will collaborate with the Genesis Consortium to help accelerate the scale-up and commercialization of biology-driven start-ups. ADM will leverage its expertise in fermentation, in particular, to accelerate the commercialization of potentially disruptive start-up innovations.
